12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Synavive: Completed Phase IIb enrollment

Zalicus completed enrollment of 292 patients with moderate to severe RA in the double-blind, placebo-controlled, international Phase IIb SYNERGY trial comparing once-daily Synavive vs. monotherapy with once-daily...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >